COMP <GO>
MPLT vs DMAC // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
MapLight Therapeutics Inc. (NASDAQ) VS. DiaMedica Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: MPLT 1
— DMAC 2
■ METRIC PARITY
LAST: $6.78 (-10.55%) • MKT CAP: $491.0M
options-implied-move
—
LAST: $9.29 (+0.43%) • MKT CAP: $498.8M
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MPLT VS. DMAC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MPLT | DMAC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.40% | -35.00% | +2.60 | MPLT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -5.67% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 2/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 32.7 | 61.0 | -28.30 | DMAC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $491.0M | $498.8M | -$7.8M | DMAC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MPLT REV | DMAC REV | MPLT GROSS % | DMAC GROSS % | MPLT FCF | DMAC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $473.4M | $96.3M | — | — | -$138.6M | -$29.1M |
| FY 2024 | $232.2M | $74.7M | — | — | -$79.6M | -$22.1M |
| FY 2023 | — | $59.5M | — | — | — | -$18.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MPLT // BETA —
DMAC // BETA —